-
Mashup Score: 10CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy - 13 hour(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3Oncology Brothers Live Event (ASCO GI 25) - 1 day(s) ago
Get tickets online for Oncology Brothers Live Event (ASCO GI 25) here.
Source: oncologybrothers.regfox.comCategories: General Medicine News, Partners & KOLsTweet-
Register here: https://t.co/uP6375KKUS Look forward to seeing/meeting you all in person!! https://t.co/w33YvJXxWi
-
-
Mashup Score: 18Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens - 2 day(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#ASH24 #Leukemia Highlights w/ @beatalleukemia - #KOMET007 - #CPX351 - #Venetoclax + Induction Full 📢: - https://t.co/wwo9Lfd9pq - https://t.co/uId0JSrSk0 - Also on “Oncology Brothers” podcast #MedTwitter #HemeTwitter #leuksm @TargetedOnc #OncTwitter @ASH_hematology https://t.co/NRvUH9yZB4
-
-
Mashup Score: 3
Human epidermal growth factor receptor 2 (HER2) overexpression or amplification (ERBB2amp) are biomarkers for approved anti-HER2 therapies. ERBB2amp may better predict response compared with immunohistochemistry or in situ hybridization, and …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
@BijoyTelivala @RenoHemonc @ShaalanBeg If you cannot do repeat testing/biopsy, I would take the chance and proceed with anti-her2 therapy. This was a real world data/analysis by @KlempnerSam et al https://t.co/3Trd6eMDbl “ERBB2 CN was predictive of rwPFS as a continuous variable for patients treated with… https://t.co/oXfl0vzRm5
-
-
Mashup Score: 282nd line treatment in advanced HCC and when to switch - 8 day(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#GISeries: #Hepatocellular Ca 2/4: 2L Rx and when to switch! @LorenzaRimassa @ArndtVogel 🌟IO, TKIs, #supponc in 2L 🌟AEs/Management Full 🗣️ - https://t.co/PuiNqC09BC - https://t.co/HvVjU6K9DI - Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism @OncoAlert https://t.co/BD0dxdTgTM
-
-
Mashup Score: 53Oncology Brothers Event Registration - 12 day(s) ago
Thank you for your interest in attending the Oncology Brothers’ live event, “Advancements in Oncology: Today’s Data for Tomorrow’s Practice,” hosted by Drs. Rahul and Rohit Gosain, coinciding with SABCS 2024. Event Details: Date: Wednesday, December 11, 2024 Time: 7-9 PM (7 PM: Cocktails & Networking; 7:30-9 PM: Panel Discussions) Location: The Moon’s Daughter @ The Thompson Hotel; 115 Lexington Ave, 20th Fl, San Antonio, TX For questions, changes, or other inquiries please contact Kerrie Keegan: Kerrie@SignifyMD.com
Source: docs.google.comCategories: General Medicine News, Partners & KOLsTweet-
Going to be at #SABCS24? Let’s discuss the current SoC & how the data from #SABCS24 is impacting our practice! InPerson: Dec 11, 2024 w/ @DrSGraff @curijoey @hmcarthur @DrGattiMays @drsarahsam @Neil_Iyengar Register https://t.co/l6gxYlEiyq #AdvInOnc24 #bcsm #OncTwitter https://t.co/IPItA5aSL2
-
-
Mashup Score: 53Oncology Brothers' Event Registration - 14 day(s) ago
Thank you for your interest in attending the Oncology Brothers’ live event, “Advancements in Oncology: Today’s Data for Tomorrow’s Practice,” hosted by Drs. Rahul and Rohit Gosain, coinciding with ASH 2024. Event Details: Date & Time: Sunday, December 8, 2024 | 6:30-8:30 PM PST Time: 6:30-8:30 PM (6:30 PM: Cocktails & Networking; 7-8:30 PM: Panel Discussions) Location: Skybox Penthouse at DiamondView Tower | 350 Tenth Ave, 15th Fl, San Diego, CA For questions, changes, or other inquiries please contact Kerrie Keegan: Kerrie@SignifyMD.com
Source: docs.google.comCategories: General Medicine News, Partners & KOLsTweet-
Going to #ASH24? See you there to discuss the current SoC & how the data from #ASH24 will change our practice! InPerson: Dec 8, 2024 w/ @CarrawayHetty @Dr_AmerZeidan @VincentRK @DrAEvens @Ccostello7 @DrLaCasce Register https://t.co/sU9IJYuxz7 #AdvInOnc24 #HemeTwitter https://t.co/PtFdUOcNeK
-
-
Mashup Score: 19
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Source: www.targetedonc.comCategories: General Medicine News, Hem/OncsTweet-
@BijoyTelivala @FDA @RManochakian @EileenMOReilly @StephenVLiu @GIcancerDoc @NarjustFlorezMD @RenoHemonc @dr_yakupergun @ADesaiMD @lungoncdoc This editorial by @GIcancerDoc @DRCamidge @StephenVLiu and @MPishvaian is a good one. - 0.3-1% prevalence - Poor outcomes for NRG1 w/ chemo (particularly low response with ICI) https://t.co/F6W8u33YLO @TargetedOnc
-
-
Mashup Score: 42From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer - 19 day(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
Approval is just a start, managing AEs for these💊matters as much. #ToxCheck for commonly used ADCs w/ @ErikaHamilton9 ➕@TiansterZhang ⭐️#EV #Sacituzumab #TDxD Full 🗣️ - “Oncology Brothers”Podcast - https://t.co/VTux0W3kxY - https://t.co/GHgh3MigXA #OncTwitter #bcsm #gusm https://t.co/WNA5zBRQhM
-
-
Mashup Score: 53Oncology Brothers' Event Registration - 22 day(s) ago
Thank you for your interest in attending the Oncology Brothers’ live event, “Advancements in Oncology: Today’s Data for Tomorrow’s Practice,” hosted by Drs. Rahul and Rohit Gosain, coinciding with ASH 2024. Event Details: Date & Time: Sunday, December 8, 2024 | 6:30-8:30 PM PST Time: 6:30-8:30 PM (6:30 PM: Cocktails & Networking; 7-8:30 PM: Panel Discussions) Location: Skybox Penthouse at DiamondView Tower | 350 Tenth Ave, 15th Fl, San Diego, CA For questions, changes, or other inquiries please contact Kerrie Keegan: Kerrie@SignifyMD.com
Source: docs.google.comCategories: General Medicine News, Partners & KOLsTweet-
Going to #ASH24? See you there to discuss the current SoC & how the data from #ASH24 will change our practice! InPerson: Dec 8, 2024 w/ @CarrawayHetty @Dr_AmerZeidan @VincentRK @DrAEvens @Ccostello7 @DrLaCasce Register https://t.co/sU9IJYuxz7 #AdvInOnc24 #HemeTwitter https://t.co/PtFdUOcNeK
-
#ToxCheck: CART is approved for multiple heme malignancies. Join @SurbhiSidanaMD & @Lymphoma_Doc as we discuss key AEs & management strategies: Full 📢 ⭐️ https://t.co/un7L9NX4FR ⭐️ https://t.co/O9Dy7oWWhf ⭐️ “Oncology Brothers” podcast #MedTwitter #HemeTwitter #mmsm #lymsm https://t.co/hcZbWMs16N